Cellectis (CLLS) Interest & Investment Income (2022 - 2026)

Cellectis (CLLS) recorded quarterly Interest & Investment Income of $11.9 million in Q1 2026, down 15.7% quarter-over-quarter from $14.1 million in Q3 2025, and up 88.84% on a YoY basis from $6.3 million in Q1 2025.

Cellectis (CLLS) Interest & Investment Income (2022 - 2026) Analysis & Trends

Cellectis' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $11.9 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income rose 88.84% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $11.9 million (up 88.84% YoY), while the FY2025 annual figure was $16.1 million, down 63.69% from the prior year.
  • Interest & Investment Income was $11.9 million for Q1 2026 at Cellectis, down from $14.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $29.7 million in Q3 2024 to a low of $775000.0 in Q1 2023.
  • Historically, Interest & Investment Income has averaged $13.3 million across 5 years, with a median of $11.9 million in 2026.
  • The sharpest annual moves came in 2024 and 2025: Interest & Investment Income surged 3694.84% in 2024, then sank 78.59% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at $15.2 million in 2022, then tumbled by 64.73% to $5.3 million in 2023, then soared by 456.06% to $29.7 million in 2024, then sank by 52.54% to $14.1 million in 2025, then fell by 15.7% to $11.9 million in 2026.
  • The last three Interest & Investment Income figures came in at $11.9 million (Q1 2026), $14.1 million (Q3 2025), and $11.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 11.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.89 Mn
Sep 30, 2025 14.11 Mn
Jun 30, 2025 11.58 Mn
Mar 31, 2025 6.30 Mn
Sep 30, 2024 29.73 Mn
Jun 30, 2024 29.41 Mn
Mar 31, 2024 29.41 Mn
Dec 31, 2023 5.35 Mn
Sep 30, 2023 4.92 Mn
Mar 31, 2023 775,000.00
Sep 30, 2022 15.16 Mn
Jun 30, 2022 12.26 Mn
Mar 31, 2022 2.27 Mn